共 50 条
Efficacy of integrated Traditional Chinese Medicine and anti-retroviral therapy on immunological nonresponse in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: a Meta-analysis of randomized controlled trials
被引:0
|作者:
Tao Zhuang
[1
,2
,3
]
Huang Xiaojie
[2
]
Liu Ying
[3
]
Wang Ru
[4
]
Dong Jipeng
[3
]
Liang Biyan
[3
]
Zou Wen
[3
]
Gao Guojian
[3
]
Wang Zhuo
[1
]
Zhang Ke
[5
]
Wu Hao
[2
]
Zhang Tong
[2
]
Wang Jian
[3
]
机构:
[1] China Acad Chinese Med Sci, Inst Basic Theory Chinese Med, Beijing 100700, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing 100069, Peoples R China
[3] China Acad Chinese Med Sci, Res Ctr AIDS Treatment Tradit Chinese Med, Beijing 100700, Peoples R China
[4] China Acad Chinese Med Sci, Ctr Cardiovasc Dis, Xiyuan Hosp, Beijing 100091, Peoples R China
[5] Qingdao Univ, Dermatol Dept, Qingdao 266000, Peoples R China
关键词:
Medicine;
Chinese Traditional;
HIV;
acquired immunodeficiency syndrome;
immunological nonresponse;
anti-retroviral agents;
Meta-analysis;
IMMUNE RECONSTRUCTION;
HIV-1;
SAFETY;
RECONSTITUTION;
ACTIVATION;
RECOVERY;
D O I:
10.19852/j.cnki.jtcm.2021.05.002
中图分类号:
R [医药、卫生];
学科分类号:
10 ;
摘要:
OBJECTIVE: To explore the efficacy of integrating Traditional Chinese Medicine (TCM) and anti-retroviral therapy (ART), a customized combination of different classes of medications which was also called cock-tail treatment, on the immunological nonresponse (INR) in people living with human immunodeficiency virus (HIV) (PLWH). METHODS: Relevant literature in databases such as China National Knowledge Infrastructure Database (CNKI), Wanfang Digital Journal, Chinese Medical Journal Database (CMJD), Chinese Biomedical Literature Database (CBM), PubMed, Cochrane, and Embase was reviewed by two independent investigators. Data were extracted from the studies according to the eligible criteria and analyzed using Review Manager 5.3. RESULTS: Nine randomized controlled trials (RCTs) with 1078 patients were analyzed. Our analyses showed that CD4 T cell counts in the treatment group improved compared with that in the control group [mean difference (MD) = 13.51, 95% confidence interval (0): 7.42-19.60, P < 0.00011 There was no significant difference between the treated and control groups after 3 months (MD = 25.31, 95% Cl: -2.78 to 53.41, P = 0.08). However, after 6 and 12 months, the response of the treatment group was superior to the control group (MD = 27.45, 95% CI: 7.09-47.81, P = 0.008 and MD = 27.34, 95% CI: 6.31 - 48.37, P= 0.01, respectively). The clinical efficacy of the treatment group was also higher than that of the control group (RR = 1.75, 95% CI: 1.16-2.65, P = 0.007). However, CD45RO and CD45RA T cell counts did not differ significantly between the two groups (MD = 12.37, 95% CI: -6.71 to 31.45, P = 0.20 and MD = 5.67, 95% CI: - 3.00 to14.35, P= 0.20, respectively). CONCLUSION: The combined treatment strategy of integrated TCM and Western Medicine promotes long-term reconstitution of the immune system and thus, is beneficial and has potential use for improving INR in PLWH. However, large-scale RCTs are required to provide evidence for optimal intervention strategies. (C) 2021 JTCM. All rights reserved.
引用
收藏
页码:669 / 676
页数:8
相关论文